Ischemic Stroke Hospitalized Clinical Trial
Official title:
National, Multicenter, Prospective Study of Screening of Fabry Disease in a Population of Men Over 28 Days Old and Less Than 55 Years, Hospitalized for an Ischemic Stroke.
Fabry disease is a genetic disease due to an enzymatic deficit. A screening of this disease
allows patients to benefit from an enzyme replacement therapy and prevent the occurrence of
life threatening manifestations such as an ischemic stroke.
The purpose of the study is to determinate the prevalence of Fabry disease in a population
of male patients hospitalized for an ischemic stroke.
This study, with a screening of Fabry disease, allows the patients to make a precise
diagnosis of their ischemic stroke and to facilitate the screening of the other members at
the facility.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment